(Q38975450)

http://europepmc.org/abstract/PMC/5330710

20 May 2018

title

Pharmacoepidemiology of Clinically Relevant Hypothyroidism and Hypertension from Sunitinib and Sorafenib (English)

1 reference

http://europepmc.org/abstract/PMC/5330710

20 May 2018

author

Ninh M La-Beck

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28167571%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Christine M Walko

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28167571%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Ronald E Aubert

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28167571%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Gosia Clore

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28167571%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Vivian Herrera

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28167571%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Helen Kourlas

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28167571%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Robert S Epstein

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28167571%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Howard L McLeod

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28167571%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

publication date

6 February 2017

1 reference

http://europepmc.org/abstract/PMC/5330710

20 May 2018

published in

Oncologist

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28167571%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28167571%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28167571%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

208-212

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28167571%20AND%20SRC:MED&resulttype=core&format=json

Risk of cardiovascular toxicities in patients with solid tumors treated with sunitinib, axitinib, cediranib or regorafenib: an updated systematic review and comparative meta-analysis

11 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5330710

Incidence and risk of sorafenib-induced hypertension: a systematic review and meta-analysis

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5330710

Thyroid dysfunction in patients treated with sunitinib or sorafenib

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5330710

Management of hypertension in angiogenesis inhibitor-treated patients

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5330710

Risk of hypertension and renal dysfunction with an angiogenesis inhibitor sunitinib: systematic review and meta-analysis

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5330710

The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5330710

Incidence and risk of hypertension with sorafenib in patients with cancer: a systematic review and meta-analysis

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5330710

Sunitinib induces hypothyroidism in advanced cancer patients and may inhibit thyroid peroxidase activity

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5330710

Role of tyrosine kinase inhibitors in cancer therapy

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5330710

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5330710

Risk adjustment using automated ambulatory pharmacy data: the RxRisk model

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5330710

A chronic disease score from automated pharmacy data

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5330710

Incidence of thyroid hormone therapy in patients treated with sunitinib or sorafenib: a cohort study.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5330710

Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5330710

Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5330710

In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5330710

A Novel Tyrosine-Kinase Selective Inhibitor, Sunitinib, Induces Transient Hypothyroidism by Blocking Iodine Uptake

21 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28167571

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28167571

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1634/THEONCOLOGIST.2016-0233

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28167571%20AND%20SRC:MED&resulttype=core&format=json

release_7bfg4l7wkjfe5mj6ys7uv2jf5m

11 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7bfg4l7wkjfe5mj6ys7uv2jf5m

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28167571%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

PubMed publication ID

28167571

1 reference